Long-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diabetes

Authors

• Michelle D. Lundholm, Cleveland Clinic, Cleveland, OH
• Sarah Kirschling, Cleveland Clinic, Cleveland, OH
• Bo Hu, Cleveland Clinic, Cleveland, OH
• Ali Aminian, Cleveland Clinic, Cleveland, OH
• David E. Arterburn, Kaiser Permanente Washington Health Research Institute, Seattle, WA
• Anita P. Courcoulas, University of Pittsburgh, Pittsburgh, PA
• David E. Cummings, University of Washington and VA Puget Sound Health Care System, Seattle, WA
• William F. Gourash, University of Pittsburgh, Pittsburgh, PA
• Mary Elizabeth Patti, Harvard Medical School, Boston, MA
• Philip R. Schauer, Pennington Biomedical Research Center, Baton Rouge, LA
• Donald C. Simonson, Harvard Medical School, Boston, MA
• Ashley H. Vernon, Harvard Medical School, Boston, MA
• John P. Kirwan, Pennington Biomedical Research Center, Baton Rouge, LA
• Sangeeta R. Kashyap, Weill Cornell Medicine, New York, NY

Document Type

Article

Publication Date

9-12-2024

Publication Title

Diabetes, Obesity and Metabolism

First Page

6055

Last Page

6061

DOI

10.1111/dom.15932

Rights

© 2024 John Wiley & Sons Ltd.

Recommended Citation

Lundholm, Michelle D.; Kirschling, Sarah; Hu, Bo; Aminian, Ali; Arterburn, David E.; Courcoulas, Anita P.; Cummings, David E.; Gourash, William F.; Patti, Mary Elizabeth; Schauer, Philip R.; Simonson, Donald C.; Vernon, Ashley H.; Kirwan, John P.; and Kashyap, Sangeeta R., "Long-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diabetes" (2024). LSU-LCMC Cancer Center Faculty Publications. 120.
https://digitalscholar.lsuhsc.edu/llcc_facpubs/120
10.1111/dom.15932